Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Capital return update

2 Nov 2015 07:00

RNS Number : 1496E
Quindell PLC
02 November 2015
Β 

ο»Ώ

Β 

Β 

Β 

2 November 2015

Quindell Plc

Β 

("Quindell" or the "Company" or the "Group")

Β 

Capital return update

Β 

Quindell Plc (AIM:QPP.L) announces that, pursuant to previously stated commitments, the Board of Directors of Quindell plc (the "Board") has decided to pursue a two stage distribution of 100 pence per share, with an initial, Court approved, capital repayment to shareholders of 90 pence per share and expects to seek Court approval for this to be made to shareholders in December 2015 at a total cost of approximately Β£415 million.

Β 

In consultation with its legal and financial advisers, and following detailed internal and external consideration of the Company's actual and prospective contingent creditors, the Board considers that an initial, Court approved, capital repayment to shareholders of 90 pence per share is both prudent and appropriate. The Board's intention is to make the second stage payment to shareholders of a further 10 pence per share in cash following the anticipated release at the end of 2016 of the Β£50m (which would represent approximately 11 pence per share) warranty escrow put in place as part of the disposal of the Professional Services Division ("PSD"). The Company will also seek to make this payment to shareholders in a tax and cost efficient manner.

Β 

In addition, and as previously announced, the Company will make further distributions as contingent consideration from the disposal of the PSD is realised. As previously detailed, the Company has performed a preliminary valuation exercise based on the information available at the point of disposal and has determined that a prudent estimate of the current value of the contingent consideration is approximately Β£39.6m.

Β 

The Board confirms that there have been no material changes to the value of the Company's assets, nor its actual or prospective, contingent creditors (including to regulatory bodies or prospective litigation) since previously detailed to the market. The trading assumptions of the Group's businesses remain in line with previously stated expectations.

Β 

The Company expects to issue a circular relating to the capital repayment to shareholders on 11 November 2015, with a Court hearing to follow on 16 December 2015. On such timetable, the Company would convene the required General Meeting on 26 November 2015.

Β 

For further information:

Β 

Quindell Plc

Tel: 01489 864 200

Richard Rose, Non-executive Chairman

Indro Mukerjee, Group Chief Executive Officer

Stephen Joseph, Head of Investor Relations

Tulchan Communications

Tel: 020 7353 4200

Susanna Voyle

Victoria Huxster

Β 

Peel Hunt LLP, Nominated Adviser and broker

Β 

Tel: 020 74188900

Dan Webster

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCFSFSMEFISELF
Date   Source Headline
10th Feb 20207:00 amRNSPre-close update
7th Feb 20207:00 amRNSCompletion of the sale of Healthcare Services
3rd Feb 20207:00 amRNSUpdate re the sale of Healthcare services business
23rd Jan 20207:00 amRNSChange of Auditor
10th Jan 20204:40 pmRNSSecond Price Monitoring Extn
10th Jan 20204:35 pmRNSPrice Monitoring Extension
8th Jan 202011:09 amRNSHolding(s) in Company
8th Jan 202010:47 amRNSHolding(s) in Company
31st Dec 20198:00 amRNSUpdate re the sale of Healthcare services business
23rd Dec 201912:03 pmRNSHolding(s) in Company
17th Dec 20192:22 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSUpdate re the sale of Healthcare services business
22nd Oct 20194:10 pmRNSHolding(s) in Company
22nd Oct 20194:10 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSettlement with Slater & Gordon (UK) 1 Limited
16th Oct 20194:37 pmRNSSettlement with Mr Robert Terry and others
17th Sep 20197:00 amRNSSale of Healthcare Services
4th Sep 20197:00 amRNSHalf-year Report
29th Aug 20197:03 amRNSCounterclaim against Slater & Gordon (UK) 1 Ltd
31st Jul 20197:00 amRNSAppointment of Nominated Adviser and Broker
5th Jul 20195:04 pmRNSHolding(s) in Company
1st Jul 20197:00 amRNSDirectorate Change
26th Jun 20192:14 pmRNSResult of AGM
13th Jun 20197:00 amRNSProposed counterclaim by Robert Terry and others
6th Jun 201910:23 amRNSHolding(s) in Company
3rd Jun 20197:00 amRNSAnnual Financial Report
9th May 20197:00 amRNSFinal Results
4th Apr 20191:32 pmRNSHolding(s) in Company
3rd Apr 201910:24 amRNSHolding(s) in Company
28th Mar 201910:25 amRNSHolding(s) in Company
12th Feb 20194:14 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSPre-close trading update
24th Dec 20187:00 amRNSHolding(s) in Company
3rd Dec 20182:31 pmRNSHolding(s) in Company
6th Nov 20184:57 pmRNSHolding(s) in Company
11th Oct 20183:33 pmRNSHolding(s) in Company
9th Oct 20185:20 pmRNSHolding(s) in Company
25th Sep 20185:50 pmRNSHolding(s) in Company
13th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSHalf-year Report
23rd Aug 201810:39 amRNSHolding(s) in Company
2nd Aug 20182:20 pmRNSHolding(s) in Company
29th Jun 201810:35 amRNSHolding(s) in Company
27th Jun 201811:55 amRNSAGM Results
17th May 20187:34 amRNSAnnual Financial Report
1st May 201812:27 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSFinal Results
13th Apr 20184:21 pmRNSHolding(s) in Company
16th Mar 201810:40 amRNSHolding(s) in Company
20th Feb 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.